| Understanding and Implementing a Quality by Design Program - By AtoZ Compliance | |
|
United States - NY - New Hyde Park |
|
| Hosted by: | AtoZ Compliance |
| Venue: | Online |
| Dates: | May 26, 2017 through May 26, 2017 |
|
Description |
|
| Key Take Away: This training will explain the main principles behind a QbD approach and provide guidelines on how to implement the concepts into a pharmaceutical development organization. Overview: The benefits of applying the QbD principles in the pharmaceutical industry have been well advertised. Most important are the direct benefits to our primary customer; the patient. Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration “All products are designed and developed to be of high quality; QbD provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.” Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation. However, implementing these principles into the pharmaceutical development culture can be challenging. QbD involves a complex set of interactions, technologies and systems that are not easy to grasp. Why Should You Attend: Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application. Areas Covered In This Webinar : QbD principles discussed include Quality Target Product Profile (QTPP) Risk Assessment Using Models Design of Experiments Developing a Design Space Process Analytical Technology (PAT) FMEA and Control Plan Target Operational Profile Control Strategy Learning Objectives: Prepare individuals to better understand the principles behind using QbD to develop a pharmaceutical product Understand what is meant by Quality be Design Understand the benefits from applying a QbD approach Provide key steps to implement a QbD program Understand what the important tools used to implement a QbD approach Who Will Benefit : This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms. This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products. Following personnel will benefit from the course: Senior quality managers Quality professionals Regulatory professionals Compliance professionals Production supervisors Manufacturing engineers Production engineers Process owners Quality engineers Quality auditors Development professionals Senior development managers Level: Intermediate For more information, please visit : http://bit.ly/2puMREb Email: support@atozcompliance.com Toll Free: +1- 844-414-1400 Tel: +1-516-900-5509 Speakers Profile : Steven Laurenz Steven Laurenz– Chemical Engineering M.S. – Michigan State University Expertise: Over 25 years of technical leadership experience in product development, process development, technology transfer, and process optimization. Skilled in taking new products from early laboratory stage to successful manufacturing launch. Expert in integrating Quality by Design and risk management into product development. Experience in establishing a Quality System for a R&D Quality Assurance organization. Experience: Headed product development departments at Abbott Laboratories and AbbVie Inc. Leadership positions in numerous technical consortiums. Other: Black Belt certified in Business Excellence and Master Certificate in Applied Statistics |
|
| Additional Information | |
| Event URL: | http://bit.ly/2puMREb |
| ISCB Member Discount: | None |
| Contact Person: | AtoZ Compliance ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
